A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants
A Phase I Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Adults, Children and Infants
Sponsor: Guangxi Center for Disease Control and Prevention
A PHASE1 clinical study on Hand, Foot and Mouth Disease, this trial is completed. The trial is conducted by Guangxi Center for Disease Control and Prevention and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Nov 2023 — Jul 2024 [monthly]
Completed PHASE1
-
Oct 2023 — Nov 2023 [monthly]
Completed PHASE1
-
Dec 2022 — Oct 2023 [monthly]
Completed PHASE1
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guangxi Center for Disease Control and Prevention
- Institute of Medical Biology, Chinese Academy of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .